MB Therapeutics will be present at GERPAC 2024 to share its latest innovations with healthcare professionals regarding the personalization of medicines using pharmaceutical 3D printing.

Meet the MB Therapeutics team at GERPAC 

Our start-up will be represented by our CEO, Stéphane Roulon, and our doctoral engineer, Léna Lemierre. Their presence demonstrates our commitment to innovation and research to meet the needs of healthcare professionals.

Stéphane and Léna will be present to exchange ideas, present our latest advances, and share MB Therapeutics' innovative projects. Don't miss this opportunity to meet them!

What is GERPAC ?

GERPAC (Scientific Society of pharmaceutical technology (prepared medicine) hospital pharmacists) is an annual congress that brings together hospital pharmacy professionals, the pharmaceutical industry, and researchers. This event is a major platform for exchanging knowledge and innovations in the preparation and handling of drugs in hospitals.

On the agenda:

• Conferences by experts to discuss advances in pharmacotechnics, with a particular focus on hospital pharmaceutical technologies and biotherapies.

• Interactive practical cases that provide the opportunity to solve live three current issues submitted by the participants.

• Oral communications and posters selected by the scientific committee.

MB Therapeutics' presence at this event reflects our determination to actively contribute to the evolution of the pharmaceutical sector and to establish strategic partnerships for the future.

See you in Hyères!

As a bonus, a new slogan: MADE FOR YOU MEDS

Our mission is to design tailor-made solutions, always putting the patient at the heart of our innovations.